-
1
-
-
0033971692
-
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
-
(discussion 23-4)
-
Lee L.Y., Patel S.R., Hackett N.R., et al. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac. Surg. 69:2000;14-23. (discussion 23-4).
-
(2000)
Ann Thorac. Surg.
, vol.69
, pp. 14-23
-
-
Lee, L.Y.1
Patel, S.R.2
Hackett, N.R.3
-
2
-
-
0034526510
-
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
-
Nakamura T., Mizuno S., Matsumoto K., et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106:2000;1511-1519.
-
(2000)
J. Clin. Invest.
, vol.106
, pp. 1511-1519
-
-
Nakamura, T.1
Mizuno, S.2
Matsumoto, K.3
-
3
-
-
0033520056
-
Angiogenesis gene therapy: Phase I assessment of direct intramyocardial injection of an adenovirus expressing VEGF 121 cDNA to individuals with clinically significant severe coronary artery disease
-
Rosengart T., Yee L. Angiogenesis gene therapy: phase I assessment of direct intramyocardial injection of an adenovirus expressing VEGF 121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999;468-474.
-
(1999)
Circulation
, pp. 468-474
-
-
Rosengart, T.1
Yee, L.2
-
4
-
-
0032698604
-
Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
-
Symes J., Losordo D., Vale P., et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann. Thorac. Surg. 68:1999;830-837.
-
(1999)
Ann. Thorac. Surg.
, vol.68
, pp. 830-837
-
-
Symes, J.1
Losordo, D.2
Vale, P.3
-
5
-
-
0033625185
-
Angiogenic growth factors: Potential new treatment for acute myocardial infarction?
-
Goncalves L.M. Angiogenic growth factors: potential new treatment for acute myocardial infarction? Cardiovasc. Res. 45:2000;294-302.
-
(2000)
Cardiovasc. Res.
, vol.45
, pp. 294-302
-
-
Goncalves, L.M.1
-
6
-
-
0030724190
-
Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury
-
Luo Z., Diaco M., Murohara T., et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann. Thorac. Surg. 64:1997;993-998.
-
(1997)
Ann. Thorac. Surg.
, vol.64
, pp. 993-998
-
-
Luo, Z.1
Diaco, M.2
Murohara, T.3
-
7
-
-
0031149457
-
Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals
-
Spyridopoulos I., Brogi E., Kearney M., et al. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J. Mol. Cell Cardiol. 29:1997;1321-1330.
-
(1997)
J. Mol. Cell Cardiol.
, vol.29
, pp. 1321-1330
-
-
Spyridopoulos, I.1
Brogi, E.2
Kearney, M.3
-
8
-
-
14344279280
-
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function
-
Giordano F.J., Gerber H.P., Williams S.P., et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5780-5785.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 5780-5785
-
-
Giordano, F.J.1
Gerber, H.P.2
Williams, S.P.3
-
9
-
-
0031939289
-
TerplexDNA delivery system as a gene carrier
-
Kim J., Maruyama A., Akaike T., et al. TerplexDNA delivery system as a gene carrier. Pharm. Res. 15:1998;116-121.
-
(1998)
Pharm. Res.
, vol.15
, pp. 116-121
-
-
Kim, J.1
Maruyama, A.2
Akaike, T.3
-
10
-
-
0035078206
-
Augmentation of myocardial transfection using TerplexDNA: A novel gene delivery system
-
Affleck D.G., Yu L., Bull D.A., et al. Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system. Gene Ther. 8:2001;349-353.
-
(2001)
Gene Ther.
, vol.8
, pp. 349-353
-
-
Affleck, D.G.1
Yu, L.2
Bull, D.A.3
-
11
-
-
0034720847
-
Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy
-
Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 101:2000;2981-2988.
-
(2000)
Circulation
, vol.101
, pp. 2981-2988
-
-
Sutton, M.G.1
Sharpe, N.2
-
13
-
-
0033792706
-
Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70
-
Suzuki K., Sawa Y., Kagisaki K., et al. Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70. Basic Res. Cardiol. 95:2000;397-403.
-
(2000)
Basic Res. Cardiol.
, vol.95
, pp. 397-403
-
-
Suzuki, K.1
Sawa, Y.2
Kagisaki, K.3
-
14
-
-
0030682219
-
Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction
-
Pennock G.D., Yun D.D., Agarwal P.G., et al. Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction. Am. J. Physiol. 273:1997;H2018-H2029.
-
(1997)
Am. J. Physiol.
, vol.273
-
-
Pennock, G.D.1
Yun, D.D.2
Agarwal, P.G.3
-
15
-
-
0030613355
-
Enhanced sodium-calcium exchange in the infarcted heart: Implications for excitation-contraction coupling
-
Litwin S.E., Bridge J.H.B. Enhanced sodium-calcium exchange in the infarcted heart: implications for excitation-contraction coupling. Circ. Res. 81:1997;1083-1093.
-
(1997)
Circ. Res.
, vol.81
, pp. 1083-1093
-
-
Litwin, S.E.1
Bridge, J.H.B.2
|